lomefloxacin has been researched along with Depression in 3 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Liu, W | 1 |
Wang, H | 1 |
Li, X | 1 |
Xu, Y | 1 |
Zhang, J | 1 |
Wang, W | 1 |
Gong, Q | 1 |
Qiu, X | 1 |
Zhu, J | 1 |
Mao, F | 1 |
Zhang, H | 1 |
Li, J | 1 |
Salgin-Goksen, U | 1 |
Telli, G | 1 |
Erikci, A | 1 |
Dedecengiz, E | 1 |
Tel, BC | 1 |
Kaynak, FB | 1 |
Yelekci, K | 1 |
Ucar, G | 1 |
Gokhan-Kelekci, N | 1 |
McCollum, M | 1 |
Ellis, SL | 1 |
Regensteiner, JG | 1 |
Zhang, W | 1 |
Sullivan, PW | 1 |
3 other studies available for lomefloxacin and Depression
Article | Year |
---|---|
Design, synthesis and evaluation of vilazodone-tacrine hybrids as multitarget-directed ligands against depression with cognitive impairment.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Blood-Brain Barrier; Butyrylcholinesterase; Cholin | 2018 |
New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors.
Topics: Animals; Antidepressive Agents; Depression; Hep G2 Cells; Humans; Hydrazones; Mice; Molecular Dockin | 2021 |
Minor depression and health status among US adults with diabetes mellitus.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Aged, 80 and over; Cognition Disorders; Databas | 2007 |